Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem NYT: Science By: Stephanie Nolen 18 April 2024 at 11:22 The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year. ยฉ John Wessels/Agence France-Presse โ Getty ImagesOn the way to class in Freetown, Sierra Leone. The delayed vaccines means that girls in countries such as Sierra Leone, Burkina Faso and Mozambique who are now 14 will no longer be eligible for vaccination when these campaigns finally start.
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment NYT: Science By: Apoorva Mandavilli 17 April 2024 at 18:46 New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations. ยฉ Grant Hindsley for The New York TimesKenneth Davis, a patient in an H.I.V. treatment trial, undergoes a routine exam with the assistance of Phoebe Bryson-Cahn, a research clinician, at Harborview Medical Center in Seattle.
David Egilman, Doctor Who Took On Drug Companies, Dies at 71 NYT: Science By: Clay Risen 15 April 2024 at 14:25 His testimony as an expert witness in some 600 trials helped plaintiffs win billions of dollars in cases involving malfeasance by pharmaceutical makers. ยฉ Faith Ninivaggi/ReutersDr. David Egilman in his office in Attleboro, Mass., in 2019. He spent his career taking on drug companies, such as Eli Lilly and Johnson & Johnson, trying to increase accountability.